Guide for use: | Prior to 2013, glycosylated haemoglobin levels were usually recorded as a percentage in Australia. However, the International HbA1c Consensus Committee recommends that the best way to record glycosylated haemoglobin levels is in mmol/mol. This recommendation was supported by the Australasian Association of Clinical Biochemists, the Royal College of Pathologists of Australasia, the Australian Diabetes Educators Association, and the Australian Diabetes Society. Following this, HbA1c results are now being recorded in two ways in clinical systems; as a percentage and as mmol/mol. HbA1c results should be reported for all clients, regardless of the manner in which their HbA1c is recorded. |
|---|
| Implementation in Data Set Specifications: | Implementation start date: 01/07/2014 Implementation end date: 30/06/2015 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care DSS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months.
Implementation start date: 01/07/2015 Implementation end date: 30/06/2017 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care DSS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months.
Implementation start date: 01/07/2017 Implementation end date: 30/06/2018 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care NBEDS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months.
Implementation start date: 01/07/2018 Implementation end date: 30/06/2019 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care NBEDS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months.
Implementation start date: 01/07/2019 Implementation end date: 30/06/2020 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care NBEDS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months.
Implementation start date: 01/07/2020 Implementation end date: 30/06/2021 Conditional obligation: Conditional on having had a glycosylated haemoglobin measurement result recorded within the previous 6 months or within the previous 12 months. This item is only collected for persons who have Type II diabetes. DSS specific information: In the Indigenous primary health care NBEDS, this data element relates to glycosylated haemoglobin measurement results recorded within the previous 6 months and within the previous 12 months.
Implementation start date: 01/07/2020 Implementation end date: 31/12/2020 DSS specific information: In the ISPHC NBEDS 'type 2 diabetes' specifically excludes type 1 diabetes, secondary diabetes, gestational diabetes mellitus (GDM), previous GDM, impaired fasting glucose, and impaired glucose tolerance. Data are provided to the AIHW twice, for glycosylated haemoglobin (HbA1c) measurement results recorded within the previous 6 months and within the previous 12 months (up to the census date.) Data relating to only the most recently recorded result are provided to the AIHW.
Implementation start date: 01/07/2021 Implementation end date: 31/12/2021 DSS specific information: In the ISPHC NBEDS 'type 2 diabetes' specifically excludes type 1 diabetes, secondary diabetes, gestational diabetes mellitus (GDM), previous GDM, impaired fasting glucose, and impaired glucose tolerance. Data are provided to the AIHW twice, for glycosylated haemoglobin (HbA1c) measurement results recorded within the previous 6 months and within the previous 12 months (up to the census date.) Data relating to only the most recently recorded result are provided to the AIHW.
Implementation start date: 01/07/2022 Implementation end date: 31/12/2022 DSS specific information: In the ISPHC NBEDS 'type 2 diabetes' specifically excludes type 1 diabetes, secondary diabetes, gestational diabetes mellitus (GDM), previous GDM, impaired fasting glucose, and impaired glucose tolerance. Data are provided to the AIHW twice, for glycosylated haemoglobin (HbA1c) measurement results recorded within the previous 6 months and within the previous 12 months (up to the census date.) Data relating to only the most recently recorded result are provided to the AIHW.
Implementation start date: 01/01/2021 Implementation end date: 30/06/2021 DSS specific information: In the ISPHC NBEDS 'type 2 diabetes' specifically excludes type 1 diabetes, secondary diabetes, gestational diabetes mellitus (GDM), previous GDM, impaired fasting glucose, and impaired glucose tolerance. Data are provided to the AIHW twice, for glycosylated haemoglobin (HbA1c) measurement results recorded within the previous 6 months and within the previous 12 months (up to the census date.) Data relating to only the most recently recorded result are provided to the AIHW.
Implementation start date: 01/01/2022 Implementation end date: 30/06/2022 DSS specific information: In the ISPHC NBEDS 'type 2 diabetes' specifically excludes type 1 diabetes, secondary diabetes, gestational diabetes mellitus (GDM), previous GDM, impaired fasting glucose, and impaired glucose tolerance. Data are provided to the AIHW twice, for glycosylated haemoglobin (HbA1c) measurement results recorded within the previous 6 months and within the previous 12 months (up to the census date.) Data relating to only the most recently recorded result are provided to the AIHW.
|
|---|
